IL13RA2 and central nervous system cancer: They also assessed the T-cell subtypes and various attributes of the radiolabeled CAR T cells to evaluate their overall quality, including cell viability, proliferation, activation and exhaustion markers, cytolytic activity, and release of interferon-γ when co-cultured with glioma cells expressing IL-13Rα2.